The future of COVID-19: A vaccine review

被引:13
作者
Vashi, Aksal P. [1 ]
Coiado, Olivia C. [1 ,2 ]
机构
[1] Univ Illinois, Carle Illinois Coll Med, Champaign, IL USA
[2] Univ Illinois, Grainger Coll Engn, Dept Bioengn, Dept Biomed & Translat Sci,Carle Illinois Coll Me, Champaign, IL USA
关键词
COVID-19; Vaccine; Social determinants; Health equity;
D O I
10.1016/j.jiph.2021.08.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The COVID-19 pandemic has impacted individuals, families, and communities for well over a year, and has brought light to how a broad range of social, economic, and historically relevant factors take massive tolls on the health and well-being of underserved communities around the world. This literature review aims to bring light to the current landscape of vaccines, disparities that exist in COVID-19 response, the historical relevance of the ongoing pandemic, and what needs to be accomplished for a more prepared response to potential future pandemics. It will be shown that as the world continues become more interconnected, amplification of international cooperation and well-funded response organizations are imperative to provide more equitable care in future health crises. The synthesis of current research will be helpful to researchers analyzing historical trends in the COVID-19 pandemic and individuals interested in better understanding and advocating for underserved communities across the globe. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/.)
引用
收藏
页码:1461 / 1465
页数:5
相关论文
共 40 条
  • [31] A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
    Sharma, Omna
    Sultan, Ali A.
    Ding, Hong
    Triggle, Chris R.
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [32] 1918 influenza: the mother of all pandemics
    Taubenberger, JK
    Morens, DM
    [J]. EMERGING INFECTIOUS DISEASES, 2006, 12 (01) : 15 - 22
  • [33] Terry M., 2021, BIOSPACE
  • [34] School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review
    Viner, Russell M.
    Russell, Simon J.
    Croker, Helen
    Packer, Jessica
    Ward, Joseph
    Stansfield, Claire
    Mytton, Oliver
    Bonell, Chris
    Booy, Robert
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2020, 4 (05) : 397 - 404
  • [35] Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity
    Volz, Erik
    Hill, Verity
    McCrone, John T.
    Price, Anna
    Jorgensen, David
    O'Toole, Aine
    Southgate, Joel
    Johnson, Robert
    Jackson, Ben
    Nascimento, Fabricia F.
    Rey, Sara M.
    Nicholls, Samuel M.
    Colquhoun, Rachel M.
    Filipe, Ana da Silva
    Shepherd, James
    Pascall, David J.
    Shah, Rajiv
    Jesudason, Natasha
    Li, Kathy
    Jarrett, Ruth
    Pacchiarini, Nicole
    Bull, Matthew
    Geidelberg, Lily
    Siveroni, Igor
    Goodfellow, Ian
    Loman, Nicholas J.
    Pybus, Oliver G.
    Robertson, David L.
    Thomson, Emma C.
    Rambaut, Andrew
    Connor, Thomas R.
    [J]. CELL, 2021, 184 (01) : 64 - +
  • [36] WHO, 2020, Behavioral considerations for acceptance and uptake of COVID-19 vaccines [Internet]
  • [37] Social media and vaccine hesitancy
    Wilson, Steven Lloyd
    Wiysonge, Charles
    [J]. BMJ GLOBAL HEALTH, 2020, 5 (10):
  • [38] The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
    Yang, HT
    Yang, MJ
    Ding, Y
    Liu, YW
    Lou, ZY
    Zhou, Z
    Sun, L
    Mo, LJ
    Ye, S
    Pang, H
    Gao, GF
    Anand, K
    Bartlam, M
    Hilgenfeld, R
    Rao, ZH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) : 13190 - 13195
  • [39] Yang YS, 2020, J AUTOIMMUN, V111, DOI [10.1016/j.jaut.2020.102434, 10.1016/j.jaut.2020.102487]
  • [40] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
    Zhang, Yanjun
    Zeng, Gang
    Pan, Hongxing
    Li, Changgui
    Hu, Yaling
    Chu, Kai
    Han, Weixiao
    Chen, Zhen
    Tang, Rong
    Yin, Weidong
    Chen, Xin
    Hu, Yuansheng
    Liu, Xiaoyong
    Jiang, Congbing
    Li, Jingxin
    Yang, Minnan
    Song, Yan
    Wang, Xiangxi
    Gao, Qiang
    Zhu, Fengcai
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (02) : 181 - 192